MDL Track
MDL 2994
S.D. Fla.
Environmental · claims that chronic benzene exposure from consumer products, industrial workplaces, or contaminated environments causes leukemia, lymphoma, and other blood cancers
Defendant
The 3M Company
MDL / Track
MDL 2994
S.D. Fla.
Judge
Various
Plaintiffs
ACTIVE
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
In July 2025, the U.S. District Court for the Eastern District of North Carolina denied Exxon Mobil's motion to dismiss in Dickerson v. CRC Industries, Inc., et al., allowing myelodysplastic syndrome (MDS) claims to proceed. The court held that disease claims accrue at diagnosis, not exposure cessation, and that North Carolina's repose statutes do not apply to latent occupational diseases absent express legislative inclusion. Separately, the Ninth Circuit in Bowen v. Energizer Holdings, Inc., 2024 WL 4352496 (9th Cir. Oct. 1, 2024), reversed dismissal of consumer benzene-in-sunscreen claims, finding Article III standing allegations were intertwined with merits and required factual development. No MDL consolidation is currently active for benzene exposure.
Causation Theory
Benzene is a Group 1 human carcinogen per IARC and OSHA classification. Chronic exposure damages bone marrow hematopoietic stem cells, causing chromosomal aberrations that progress to acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and aplastic anemia. A 2022 independent screening study (Environmental Health Perspectives, Vol. 130, No. 3) detected benzene in sunscreen and after-sun products, with aerosol sprays showing highest contamination levels; FDA-documented company testing found levels up to 23.6 ppm. The FDA restricts benzene to 2 ppm only where unavoidable and therapeutically necessary.
Case Management Orders
Litigation status
Consumer sunscreen cases proceed in MDL 2994 (S.D. Fla.) with bellwether trials scheduled for late 2026. Industrial exposure cases continue in state and federal courts, including a July 2025 ruling in Dickerson v. CRC Industries, Inc., E.D.N.C., denying Exxon Mobil's motion to dismiss on statute of repose grounds for MDS claims. The Ninth Circuit affirmed Article III standing in Bowen v. Energizer Holdings, 118 F.4th 1134 (9th Cir. Oct. 1, 2024), allowing sunscreen false advertising claims to proceed.
MDL Track
MDL 2994
S.D. Fla.
State Court Activity
Active industrial exposure litigation in Pennsylvania (Philadelphia CCP), North Carolina (E.D.N.C.), and California state courts; new 2026 filings against acne treatment manufacturers (benzoyl peroxide degradation claims)
Geographic exposure
IARC reclassified automotive gasoline as Group 1 human carcinogen March 2025, strengthening causation arguments. OSHA PEL: 1 ppm (8-hour TWA), 5 ppm (15-minute STEL). NIOSH recommends protection at 0.1 ppm. Over 70 consumer product recalls 2021-2024 including sunscreens, deodorants, antiperspirants. Disease latency 5-40 years for AML/MDS.
$725.5 million jury verdict awarded May 2024 to former mechanic with AML linked to benzene exposure; ExxonMobil liable for failure to warn. Philadelphia Court of Common Pleas upheld verdict September 2024, increasing total damages to $816 million. Two-year SOL from diagnosis under Pennsylvania law. Source: Reuters, May 10, 2024.
Dickerson v. CRC Industries, Inc., et al., E.D.N.C.: Court denied Exxon Mobil motion to dismiss July 2025, allowing MDS claims to proceed despite repose statute challenge. Plaintiff exposed 1970s-2006 at Weyerhaeuser facility using benzene-containing solvents. Ruling preserves disease-based claims under North Carolina's three-year discovery rule. Source: E.D.N.C. docket, July 2025 order.
Nevada Supreme Court affirmed $7.5 million verdict December 2014 for former gasoline-tanker truck driver. Precedent for transportation sector benzene exposure claims. Source: Schmidt & Clark case listings.
February 2017 filing by auto mechanic Steven J. Williams alleging myeloma after 35 years occupational exposure. Illinois jurisdiction favorable for latency-period diseases. Source: Schmidt & Clark case listings.
Stone fabricator silicosis litigation (Contreras Lopez v. artificial stone manufacturers, filed March 26, 2025, L.A. Superior Court) indicates ongoing toxic tort activity; benzene co-exposure in manufacturing settings. Source: Schmidt & Clark filing alert.
Valisure independent screening 2021: benzene detected in 192 of 661 sunscreen/after-sun products (29%), with 78 products exceeding FDA 2 ppm limit. Chemical spray formulations highest risk. FDA citizen petition filed May 24, 2021. Source: Environmental Health Perspectives, Vol. 130, No. 3 (2022).
2021 study: 80% of 50 marketed sunscreen products contained benzene; 44% exceeded cancer risk thresholds. Dermal exposure assessment shows significant non-occupational exposure pathway. Source: Pal et al., PMC10330564 (2023).
Key defendants
The 3M Company
Role: Manufacturer
Removed to SDNY (1:25-cv-06724) under federal officer jurisdiction; no corporate parent per Rule 7.1 disclosure. Early posture, no dispositive motion activity yet.
Exxon Mobil
Role: Petroleum Refiner
Motion to dismiss denied July 2025 in Dickerson v. CRC Industries (E.D.N.C.); court rejected statute of repose defense for disease-based MDS claims. Exposure now merits-phase.
PBF Energy Inc.
Role: Refinery Operator
Named in N.D. Cal. class action (3:23-cv-06142) with Martinez Refining Co. subsidiary; claims include Clean Air Act violations, medical monitoring, and ultrahazardous activity. Active discovery posture.
Martinez Refining Company LLC
Role: Refinery Subsidiary
Co-defendant with PBF Energy in N.D. Cal. benzene emissions class action; allegations of unreported toxic releases from November 2022 incident. No dismissal motion filed per docket.
| Defendant | Role | Intelligence Note |
|---|---|---|
| The 3M Company | Manufacturer | Removed to SDNY (1:25-cv-06724) under federal officer jurisdiction; no corporate parent per Rule 7.1 disclosure. Early posture, no dispositive motion activity yet. |
| Exxon Mobil | Petroleum Refiner | Motion to dismiss denied July 2025 in Dickerson v. CRC Industries (E.D.N.C.); court rejected statute of repose defense for disease-based MDS claims. Exposure now merits-phase. |
| PBF Energy Inc. | Refinery Operator | Named in N.D. Cal. class action (3:23-cv-06142) with Martinez Refining Co. subsidiary; claims include Clean Air Act violations, medical monitoring, and ultrahazardous activity. Active discovery posture. |
| Martinez Refining Company LLC | Refinery Subsidiary | Co-defendant with PBF Energy in N.D. Cal. benzene emissions class action; allegations of unreported toxic releases from November 2022 incident. No dismissal motion filed per docket. |
Timeline
First Benzene Leukemia Case Reported
Delore and Borgomano report first human case of leukemia associated with benzene exposure, establishing earliest documented link between benzene and blood cancers. Int J Occup Environ Health 13(2):213-221 (2007).
IARC Confirms Benzene Carcinogenicity
International Agency for Research on Cancer (IARC) evaluates benzene as having 'sufficient evidence' of carcinogenicity to humans, confirming causal link to leukemias. IARC Monogr Eval Carcinog Risks Hum Suppl 7.
Dickerson v. CRC Industries: MDS Claims Survive Dismissal
U.S. District Court for Eastern District of North Carolina denies Exxon Mobil's motion to dismiss in Dickerson v. CRC Industries, Inc., et al., allowing myelodysplastic syndrome claims to proceed under disease-accrual rule. Court rejects statute of repose defense, holding claims accrue at diagnosis not exposure end.
Statute of limitations
FDA 2 ppm guidance for unavoidable benzene in drugs distinguishes sunscreen as elective cosmetic use—supports failure-to-warn theories. IARC March 2025 reclassification of automotive gasoline as Group 1 carcinogen strengthens causation evidence. No nationwide tolling agreement identified.
North Carolina
3 years from diagnosis
Rule: Disease claims accrue at diagnosis, not exposure; statutes of repose held inapplicable to latent disease claims per Dickerson v. CRC Industries, Inc., et al., E.D.N.C. July 2025 (citing Dunn v. Pacific Employers Insurance Co., 1992; Wilder v. Moore, 1994; Stahle v. CTS Corp., 4th Cir.)
Discovery: Accrual at diagnosis of benzene-related illness (MDS, AML, aplastic anemia), not at end of exposure
Federal court rejected 6- and 10-year repose defenses under N.C. Gen. Stat. §§ 1-50(a)(6) and 1-52(16). Exposure ending in 2006; diagnosis 2017; filing 2019 held timely.
California
2 years from discovery of injury
Rule: Discovery rule applies; Bowen v. Energizer Holdings, Inc., 2024 WL 4352496 (9th Cir. Oct. 1, 2024) recognized Article III standing for benzene sunscreen consumer claims
9th Circuit remanded for merits determination on safety allegations; consumer benzene exposure claims remain viable.
Florida
4 years from injury
Rule: Discovery rule applies for latent diseases; MDL 2994 (Benzene Sunscreen) centralized in S.D. Fla.
Discovery: Accrual tied to diagnosis or when disease becomes apparent, not exposure date
MDL 2994 active as of January 2026. Personal injury track proceeding to trial 2026-2027. Class action settlement largely resolved; individual injury claims remain viable. Screen for: AML, MDS, leukemia diagnoses with sunscreen use 2021-2022 recall period.
Illinois
2 years from discovery of injury
Rule: 735 ILCS 5/13-202; discovery rule applies for toxic torts with latency periods
Discovery: Accrual when plaintiff knows or reasonably should know of injury and its cause
Pennsylvania
2 years from discovery of injury
Rule: 42 Pa.C.S. § 5524(2); discovery rule applies for latent diseases
Discovery: Accrual upon discovery of injury and factual basis for causation
Dickerson originally filed in Philadelphia County 2019; dismissed for jurisdictional reasons. North Carolina refile held timely.
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| North Carolina | 3 years from diagnosis | Disease claims accrue at diagnosis, not exposure; statutes of repose held inapplicable to latent disease claims per Dickerson v. CRC Industries, Inc., et al., E.D.N.C. July 2025 (citing Dunn v. Pacific Employers Insurance Co., 1992; Wilder v. Moore, 1994; Stahle v. CTS Corp., 4th Cir.) | Accrual at diagnosis of benzene-related illness (MDS, AML, aplastic anemia), not at end of exposure | Federal court rejected 6- and 10-year repose defenses under N.C. Gen. Stat. §§ 1-50(a)(6) and 1-52(16). Exposure ending in 2006; diagnosis 2017; filing 2019 held timely. |
| California | 2 years from discovery of injury | Discovery rule applies; Bowen v. Energizer Holdings, Inc., 2024 WL 4352496 (9th Cir. Oct. 1, 2024) recognized Article III standing for benzene sunscreen consumer claims | — | 9th Circuit remanded for merits determination on safety allegations; consumer benzene exposure claims remain viable. |
| Florida | 4 years from injury | Discovery rule applies for latent diseases; MDL 2994 (Benzene Sunscreen) centralized in S.D. Fla. | Accrual tied to diagnosis or when disease becomes apparent, not exposure date | MDL 2994 active as of January 2026. Personal injury track proceeding to trial 2026-2027. Class action settlement largely resolved; individual injury claims remain viable. Screen for: AML, MDS, leukemia diagnoses with sunscreen use 2021-2022 recall period. |
| Illinois | 2 years from discovery of injury | 735 ILCS 5/13-202; discovery rule applies for toxic torts with latency periods | Accrual when plaintiff knows or reasonably should know of injury and its cause | — |
| Pennsylvania | 2 years from discovery of injury | 42 Pa.C.S. § 5524(2); discovery rule applies for latent diseases | Accrual upon discovery of injury and factual basis for causation | Dickerson originally filed in Philadelphia County 2019; dismissed for jurisdictional reasons. North Carolina refile held timely. |
Live intelligence
AI litigation brief
Benzene Exposure remains active mdl with 22 current signals in the accepted feed.
Overview
Consumer sunscreen cases proceed in MDL 2994 (S.D. Fla.) with bellwether trials scheduled for late 2026. Industrial exposure cases continue in state and federal courts, including a July 2025 ruling in Dickerson v. CRC Industries, Inc., E.D.N.C., denying Exxon Mobil's motion to dismiss on statute of repose grounds for MDS claims. The Ninth Circuit affirmed Article III standing in Bowen v. Energizer Holdings, 118 F.4th 1134 (9th Cir. Oct. 1, 2024), allowing sunscreen false advertising claims to proceed.
Key developments
Trajectory
Benzene Litigation is showing regulatory movement without corresponding press or court activity — watch for downstream PACER filings triggered by these agency actions.
Editorial intelligence
MDL 2994 should stay on the lead docket watch because it is the primary consolidation vehicle for Benzene Litigation.
Generated Apr 5, 2026, 3:00 PM UTC
22 events detected
No recent news signals. Monitoring is active — this section updates automatically.
No recent PubMed signals. Monitoring is active — this section updates automatically.
This EPA Superfund site profile documents groundwater contamination in Levelland, Texas, where benzene and other chemicals have polluted the environment, creating potential exposure risks to local residents that could support blood-cancer claims tied to chronic benzene exposure.
EPA Superfund regulatory on Mar 30 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
CHARLES GEORGE RECLAMATION TRUST LANDFILL | Superfund Site Profile | Superfund Site Information | US EPA Superfund Information Systems: Site Profile ## Superfund Site: ## CHARLES GEORGE RECLAMATION TRUST LANDFILLTYNGSBOROUGH, MA ## Contaminant List Sign up for this Superfund site’s mailing list EPA has identified the chemical substances (i.e., hazardous substances, pollutants or contaminants) list
EPA Superfund regulatory on Mar 25 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
EL TORO MARINE CORPS AIR STATION | Superfund Site Profile | Superfund Site Information | US EPA Superfund Information Systems: Site Profile ## Superfund Site: ## EL TORO MARINE CORPS AIR STATIONEL TORO, CA ## Contaminant List EPA has identified the chemical substances (i.e., hazardous substances, pollutants or contaminants) listed below as contaminants of concern (COCs) for the site. COCs are the
EPA Superfund regulatory on Mar 25 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
Basic Information about Oil and Natural Gas Air Pollution Standards | US EPA # Basic Information about Oil and Natural Gas Air Pollution Standards The oil and natural gas industry includes a wide range of operations and equipment, from wells to natural gas gathering lines and processing facilities, to storage tanks, and transmission and distribution pipelines. The industry is a significant source
EPA regulatory on Mar 24 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
EPA Proposes Plan to Step Up Groundwater Cleanup at San Fernando Valley Superfund Site, Increasing Supply of Safe Drinking Water | US EPA # EPA Proposes Plan to Step Up Groundwater Cleanup at San Fernando Valley Superfund Site, Increasing Supply of Safe Drinking Water March 16, 2026 Contact Information Alejandro Diaz (diaz.alejandro@epa.gov) 808-284-7084 LOS ANGELES – U.S. Environmental Protection
EPA News Release regulatory on Mar 16 for Benzene Litigation. Regulatory developments can change intake posture and motion practice quickly.
No recent court filing signals. Monitoring is active — this section updates automatically.
No recent legislative signals. Monitoring is active — this section updates automatically.
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
90Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Apr 5, 2026, 3:00 PM UTC
Next: 16:19
Source Monitoring
PACER
PACER
Google News
PubMed
EPA
Event feed
22
events detected
AI Brief
Benzene Exposure remains active mdl with 22 current signals in the accepted feed.
Overview
Consumer sunscreen cases proceed in MDL 2994 (S.D. Fla.) with bellwether trials scheduled for late 2026. Industrial exposure cases continue in state and federal courts, including a July 2025 ruling in Dickerson v. CRC Industries, Inc., E.D.N.C., denying Exxon Mobil's motion to dismiss on statute of repose grounds for MDS claims. The Ninth Circuit affirmed Article III standing in Bowen v. Energizer Holdings, 118 F.4th 1134 (9th Cir. Oct. 1, 2024), allowing sunscreen false advertising claims to proceed.
Key developments
EPA Superfund regulatory on Mar 30: STATE ROAD 114 GROUNDWATER PLUME | Superfund Site Profile.
Generated Apr 5, 2026, 3:00 PM UTC
Tracked MDLs
MDL 2994
S.D. Fla.
← Previous
Baby Food Heavy Metals
Tracks product-liability litigation, FDA enforcement, and neurodevelopmental research tied to toxic heavy metals in commercial baby food products.
Next →
Discord Sexual Abuse
Tracks platform-design liability litigation and policy activity tied to Discord-facilitated grooming, exploitation, and sexual abuse of minors.